drugset / Trial / NCT06729840

Intralesional Treatment of Keloids

NCT06729840

Phase 3 Recruiting 45 enrolled Sohag University
RandomizedParallel-groupSingle-blindTreatment

Summary

Intralesional injection in treatment of keloid

Timeline

Start
2024-12-01
Primary completion
2025-04-01
Completion
2025-05-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Botulinum toxin type A Protein / enzyme biologic Other
Comparator Triamcinolone Acetonide Other / unclassified Other
Comparator Vitamin D Other / unclassified Other

Indications